These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 18274957)

  • 1. In vitro metabolism of KBH-A40, a novel delta-lactam-based histone deacetylase (HDAC) inhibitor, in human liver microsomes and serum.
    Kim HM; Oh SJ; Park SK; Han G; Kim K; Lee KS; Kang JS; Nam M; Lee K
    Xenobiotica; 2008 Mar; 38(3):281-93. PubMed ID: 18274957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the pharmacokinetics and metabolism of a novel histone deacetylase inhibitor, KBH-A40, in rats.
    Oh SJ; Lee K; Ryu J; Yu HE; Han G; Park SK; Kang JS; Kim HM; Kim YC
    Xenobiotica; 2011 Feb; 41(2):155-63. PubMed ID: 21070143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel delta-lactam-based histone deacetylase inhibitor, KBH-A42, induces cell cycle arrest and apoptosis in colon cancer cells.
    Kang MR; Kang JS; Han SB; Kim JH; Kim DM; Lee K; Lee CW; Lee KH; Lee CH; Han G; Kang JS; Kim HM; Park SK
    Biochem Pharmacol; 2009 Sep; 78(5):486-94. PubMed ID: 19445901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone deacetylase inhibitor KBH-A42 inhibits cytokine production in RAW 264.7 macrophage cells and in vivo endotoxemia model.
    Choi Y; Park SK; Kim HM; Kang JS; Yoon YD; Han SB; Han JW; Yang JS; Han G
    Exp Mol Med; 2008 Oct; 40(5):574-81. PubMed ID: 18985016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Major phase I biotransformation pathways of Trichostatin a in rat hepatocytes and in rat and human liver microsomes.
    Elaut G; Török G; Vinken M; Laus G; Papeleu P; Tourwe D; Rogiers V
    Drug Metab Dispos; 2002 Dec; 30(12):1320-8. PubMed ID: 12433798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro phase I cytochrome P450 metabolism, permeability and pharmacokinetics of SB639, a novel histone deacetylase inhibitor in preclinical species.
    Venkatesh PR; Goh E; Zeng P; New LS; Xin L; Pasha MK; Sangthongpitag K; Yeo P; Kantharaj E
    Biol Pharm Bull; 2007 May; 30(5):1021-4. PubMed ID: 17473456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism-related liabilities of a potent histone deacetylase (HDAC) inhibitor and relevance of the route of administration on its metabolic fate.
    Fonsi M; Fiore F; Jones P; Kinzel O; Laufer R; Rowley M; Monteagudo E
    Xenobiotica; 2009 Oct; 39(10):722-37. PubMed ID: 19569735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel gamma-lactam-based histone deacetylase inhibitor potently inhibits the growth of human breast and renal cancer cells.
    Kwon HK; Ahn SH; Park SH; Park JH; Park JW; Kim HM; Park SK; Lee K; Lee CW; Choi E; Han G; Han JW
    Biol Pharm Bull; 2009 Oct; 32(10):1723-7. PubMed ID: 19801834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of species-difference in microsomal metabolism of amitriptyline using a predictive MRM-IDA-EPI method.
    Lee JY; Lee SY; Lee K; Oh SJ; Kim SK
    Chem Biol Interact; 2015 Mar; 229():109-18. PubMed ID: 25623954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing and minimizing time-dependent inhibition of cytochrome P450 3A in drug discovery: a case study with melanocortin-4 receptor agonists.
    Tang W; Stearns RA; Wang RW; Miller RR; Chen Q; Ngui J; Bakshi RK; Nargund RP; Dean DC; Baillie TA
    Xenobiotica; 2008 Nov; 38(11):1437-51. PubMed ID: 18841517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro metabolism of the analgesic bicifadine in the mouse, rat, monkey, and human.
    Erickson DA; Hollfelder S; Tenge J; Gohdes M; Burkhardt JJ; Krieter PA
    Drug Metab Dispos; 2007 Dec; 35(12):2232-41. PubMed ID: 17881661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A metabolic screening study of trichostatin A (TSA) and TSA-like histone deacetylase inhibitors in rat and human primary hepatocyte cultures.
    Elaut G; Laus G; Alexandre E; Richert L; Bachellier P; Tourwé D; Rogiers V; Vanhaecke T
    J Pharmacol Exp Ther; 2007 Apr; 321(1):400-8. PubMed ID: 17218485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-resolution mass spectrometry-based approach for the identification and profiling of the metabolites of taletrectinib formed in liver microsomes.
    Ye Y; Guo X; He X; Zhang M; He H; Qiu D; Guo Z
    Drug Test Anal; 2021 Jun; 13(6):1118-1126. PubMed ID: 33527739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereoselective metabolism of the monoterpene carvone by rat and human liver microsomes.
    Jäger W; Mayer M; Platzer P; Reznicek G; Dietrich H; Buchbauer G
    J Pharm Pharmacol; 2000 Feb; 52(2):191-7. PubMed ID: 10714949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucuronidation converts gemfibrozil to a potent, metabolism-dependent inhibitor of CYP2C8: implications for drug-drug interactions.
    Ogilvie BW; Zhang D; Li W; Rodrigues AD; Gipson AE; Holsapple J; Toren P; Parkinson A
    Drug Metab Dispos; 2006 Jan; 34(1):191-7. PubMed ID: 16299161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro metabolism of BIIB021, an inhibitor of heat shock protein 90, in liver microsomes and hepatocytes of rats, dogs, and humans and recombinant human cytochrome P450 isoforms.
    Xu L; Woodward C; Khan S; Prakash C
    Drug Metab Dispos; 2012 Apr; 40(4):680-93. PubMed ID: 22217465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KBH-A42, a histone deacetylase inhibitor, inhibits the growth of doxorubicin-resistant leukemia cells expressing P-glycoprotein.
    Kang MR; Lee K; Kang JS; Lee CW; Lee KH; Kim JH; Yang JW; Kim BG; Han G; Kang JS; Park SK; Kim HM
    Oncol Rep; 2010 Mar; 23(3):801-9. PubMed ID: 20127023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of pyridone-based histone deacetylase inhibitors: approaches for metabolic stability.
    Cho M; Choi E; Yang JS; Lee C; Seo JJ; Kim BS; Oh SJ; Kim HM; Lee K; Park SK; Kwon HJ; Han G
    ChemMedChem; 2013 Feb; 8(2):272-9. PubMed ID: 23292995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Investigation of metabolic kinetics and reaction phenotyping of ligustrazin by using liver microsomes and recombinant human enzymes].
    Tan Y; Zhuang XM; Shen GL; Li H; Gao Y
    Yao Xue Xue Bao; 2014 Mar; 49(3):374-9. PubMed ID: 24961110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of CYP3A4 and CYP2C19 in the stereoselective metabolism of lansoprazole by human liver microsomes.
    Katsuki H; Hamada A; Nakamura C; Arimori K; Nakano M
    Eur J Clin Pharmacol; 2001 Dec; 57(10):709-15. PubMed ID: 11829200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.